Cargando…

Exacerbation frequency and course of COPD

BACKGROUND: Exacerbations affect morbidity in chronic obstructive pulmonary disease (COPD). We sought to evaluate the association between exacerbation frequency and spirometric and health status changes over time using data from a large, long-term trial. METHODS: This retrospective analysis of data...

Descripción completa

Detalles Bibliográficos
Autores principales:	Halpin, David MG, Decramer, Marc, Celli, Bartolome, Kesten, Steven, Liu, Dacheng, Tashkin, Donald P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459660/ https://www.ncbi.nlm.nih.gov/pubmed/23055714 http://dx.doi.org/10.2147/COPD.S34186

Ejemplares similares

Adverse health consequences in COPD patients with rapid decline in FEV(1 )- evidence from the UPLIFT trial
por: Kesten, Steven, et al.
Publicado: (2011)

Risk of Nonlower Respiratory Serious Adverse Events Following COPD Exacerbations in the 4-year UPLIFT(®) Trial
por: Halpin, David M. G., et al.
Publicado: (2011)

Tiotropium reduces risk of exacerbations irrespective of previous use of inhaled anticholinergics in placebo-controlled clinical trials
por: Cooper, Christopher B, et al.
Publicado: (2011)

Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial
por: Hanania, Nicola A, et al.
Publicado: (2011)

Tiotropium HandiHaler(®) in the treatment of COPD: A safety review
por: Kesten, Steven, et al.
Publicado: (2009)

Longitudinal inspiratory capacity changes in chronic obstructive pulmonary disease
por: Celli, Bartolome R, et al.
Publicado: (2012)

Defining a COPD composite safety endpoint for demonstrating efficacy in clinical trials: results from the randomized, placebo-controlled UPLIFT® trial
por: Celli, Bartolomé R., et al.
Publicado: (2016)

Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD
por: Tashkin, Donald P, et al.
Publicado: (2014)

Impact and prevention of severe exacerbations of COPD: a review of the evidence
por: Halpin, David MG, et al.
Publicado: (2017)

Mortality and Exacerbation Risk by Body Mass Index in Patients with COPD in TIOSPIR and UPLIFT
por: Putcha, Nirupama, et al.
Publicado: (2022)

Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial
por: Tashkin, Donald P., et al.
Publicado: (2018)

Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis
por: Halpin, David MG, et al.
Publicado: (2015)

Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes
por: Anzueto, A, et al.
Publicado: (2009)

Preventing and managing exacerbations in COPD – critical appraisal of the role of tiotropium
por: Tashkin, Donald P
Publicado: (2010)

Frequency of Exacerbations in COPD: An Analysis of the SPIROMICS Cohort
por: Han, MeiLan K., et al.
Publicado: (2017)

The role of bronchodilator treatment in the prevention of exacerbations of COPD
por: Wedzicha, Jadwiga A., et al.
Publicado: (2012)

Defining Disease Modification in Chronic Obstructive Pulmonary Disease
por: Halpin, David M.G., et al.
Publicado: (2009)

Altered Gene Expression in Blood and Sputum in COPD Frequent Exacerbators in the ECLIPSE Cohort
por: Singh, Dave, et al.
Publicado: (2014)

Diagnosing COPD
por: Halpin, David MG
Publicado: (2006)

Cardiac safety of tiotropium in patients with cardiac events: a retrospective analysis of the UPLIFT® trial
por: Tashkin, Donald P, et al.
Publicado: (2015)

Study design considerations in a large COPD trial comparing effects of tiotropium with salmeterol on exacerbations
por: Beeh, Kai-Michael, et al.
Publicado: (2009)

When is dual bronchodilation indicated in COPD?
por: Thomas, Mike, et al.
Publicado: (2017)

No association between exacerbation frequency and stroke in patients with COPD
por: Windsor, Claire, et al.
Publicado: (2016)

COPD management costs according to the frequency of COPD exacerbations in UK primary care
por: Punekar, Yogesh Suresh, et al.
Publicado: (2014)

Factors associated with change in exacerbation frequency in COPD
por: Donaldson, Gavin C, et al.
Publicado: (2013)

Smoking cessation in COPD: confronting the challenge
por: Tashkin, Donald P.
Publicado: (2021)

A review of nebulized drug delivery in COPD
por: Tashkin, Donald P
Publicado: (2016)

Clinical Features according to the Frequency of Acute Exacerbation in COPD
por: Lee, Seung Jun, et al.
Publicado: (2012)

Lifestyle Changes and Exacerbation Frequency of COPD in Times of the Pandemic
por: Akyıl, Fatma Tokgöz, et al.
Publicado: (2022)

ABCD of the phosphodiesterase family: interaction and differential activity in COPD
por: Halpin, David MG
Publicado: (2008)

Association between lung function and exacerbation frequency in patients with COPD
por: Hoogendoorn, Martine, et al.
Publicado: (2010)

Eight-step method to build the clinical content of an evidence-based care pathway: the case for COPD exacerbation
por: Lodewijckx, Cathy, et al.
Publicado: (2012)

Tiotropium might improve survival in subjects with COPD at high risk of mortality
por: Burgel, Pierre-Régis, et al.
Publicado: (2014)

Recommendations for the early diagnosis of COPD: the AIMAR view
por: Celli, Bartolome R
Publicado: (2015)

Natural history of COPD: gaps and opportunities
por: Agustí, Alvar, et al.
Publicado: (2017)

COPD exacerbations in general practice: variability in oral prednisolone courses
por: de Vries, Marianne, et al.
Publicado: (2012)

COPD: time to improve its taxonomy?
por: Celli, Bartolomé R., et al.
Publicado: (2018)

Effect of thyroid function on COPD exacerbation frequency: a preliminary study
por: Sarinc Ulasli, Sevinc, et al.
Publicado: (2013)

Blood neutrophil counts are associated with exacerbation frequency and mortality in COPD
por: Lonergan, Mike, et al.
Publicado: (2020)

Defective monocyte-derived macrophage phagocytosis is associated with exacerbation frequency in COPD
por: Singh, R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tdp44u7v1502ct64tm379gnrca